Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Xopenex Hfa Generic Name & Formulations
Legal Class
Rx
General Description
Levalbuterol (as tartrate) (single-isomer albuterol) 45mcg/inh; metered dose inhaler; CFC-free.
Pharmacological Class
Beta-2 agonist.
How Supplied
Inhaler w. actuator (200 inh)—15g
Manufacturer
Generic Availability
NO
Xopenex Hfa Indications
Indications
Bronchospasm.
Xopenex Hfa Dosage and Administration
Adults and Children
<4yrs: not established. ≥4yrs: 2 inh every 4–6hrs; or 1 inh every 4hrs may suffice.
Xopenex Hfa Contraindications
Not Applicable
Xopenex Hfa Boxed Warnings
Not Applicable
Xopenex Hfa Warnings/Precautions
Warnings/Precautions
Do not exceed recommended dose. Monitor for increased need; if inadequate control, reevaluate and consider adding an antiinflammatory (eg, corticosteroids). Sensitivity to sympathomimetics. Discontinue if paradoxical bronchospasm, cardiovascular effects, or hypersensitivity reactions occur. Cardiovascular disorders (esp. coronary insufficiency, arrhythmias, hypertension). Seizure disorders. Diabetes. Hyperthyroidism. Hypokalemia. Renal impairment; monitor (esp. in elderly). Elderly. Labor & delivery. Pregnancy. Nursing mothers.
Xopenex Hfa Pharmacokinetics
See Literature
Xopenex Hfa Interactions
Interactions
Avoid within 2 weeks of MAOIs, tricyclic antidepressants. Avoid other short-acting sympathomimetic aerosol bronchodilators, epinephrine. Antagonized by β-blockers. Caution with other drugs that may lower serum potassium (eg, diuretics). Monitor digoxin.
Xopenex Hfa Adverse Reactions
Adverse Reactions
Accidental injury, bronchitis, dizziness, pharyngitis, rhinitis, vomiting, palpitations, chest pain, tachycardia, headache, tremor, nervousness.
Xopenex Hfa Clinical Trials
See Literature
Xopenex Hfa Note
Not Applicable
Xopenex Hfa Patient Counseling
See Literature
Images
